The aim of growth investing is to build significant wealth. Targeting companies that are briskly growing revenue can be a lucrative approach to investing. In the past five years, the genetic diagnostics company Veracyte (NASDAQ: VCYT) has produced cumulative total returns of 116% for shareholders.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles